IRINOTECAN FOLLOWED BY FLUOROURACIL AND LEUCOVORIN IN TREATING PATIENTS WITH STAGE III OR STAGE IV COLORECTAL CARCINOMA (CANCER), OTHER REFRACTORY CARCINOMA, OR METASTATIC ADENOMA (CANCER) OF UNKNOWN PRIMARY ORIGIN: